ZIOP-PGEN Fundamental & Technical Discussion Board - CAR T Cells: Off the Shelf and On the Mark - ZIOP-PGEN Fundamental & Technical Discussion Board - InvestorVillage


This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: ZIOP-PGEN Fundamental & Technical Discussion Board   /  Message Board  /  Read Message

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  24988 of 25184  at  9/26/2021 2:42:35 PM  by

clsm

The following message was updated on 9/26/2021 6:08:21 PM.

 In response to msg 24985 by  dachmeister4u
view thread

Re: CAR T Cells: Off the Shelf and On the Mark

Yes, high doses are given, with this patient receiving 53B TCR-T cells targeting p53 https://youtu.be/IbPBCFrGs_M?t=2287

Speaking of TCR-T, ADAP and Genentech are working on two versions (both iPSC-derived), one of which is personalised https://www.globenewswire.com/news-release/2021/09/07/2292303/35803/en/Adaptimmune-Enters-into-a-Strategic-
Collaboration-with-Genentech-to-Research-Develop-and-Commercialize-Cancer-targeted-Allogeneic-T-cell-Therapies.html


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...